1 not yet recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow IKT-001: new trials by email Literature Review of IKT-001 trials Research Report on IKT-001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) IKT-001 - Pulmonary Arterial Hypertension (PAH) | Phase 3 | Not yet recruiting | Inhibikase Therapeutics | 484 | 2026-10-23 | 2026-06-08 |
| An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) IKT-001, Placebo - Pulmonary Arterial Hypertension | Phase 3 | Recruiting | Inhibikase Therapeutics | 486 | 2026-04-23 | 2026-09-02 |
Pulmonary Arterial Hypertension (2)
Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Portugal (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)